BCL2 and rosacea: ROC curve analysis further validated the diagnostic potential of these genes, with XDH exhibiting an AUC of 0.967, RXRA with 0.916, and BCL2 with 0.693, highlighting XDH and RXRA as robust biomarkers for rosacea.